Intellectual property: patents (contentious and non-contentious) in London

Allen & Overy LLP

Leveraging its significant global footprint, Allen & Overy LLP’s London IP litigation practice has been making an impact in expansive, multijurisdictional patent litigation for global telecoms and technology clients. Neville Cordell ('an extremely sophisticated and astute lawyer'), Mark Heaney ('a ferocious appetite to ensure the best outcome for his clients'), 'class act' Mark Ridgway and the 'bright, extraordinarily charming and tactically astute' senior associate James Fox continue to be instructed on big-ticket FRAND and SEP litigation for household-name companies. Marjan Noor and senior associate Rafi Allos have secured numerous wins in the life sciences sector relating to UK patent revocation actions. The firm's dedicated transactional IP offering includes co-head Jim Ford, who acts for cutting-edge AI companies, and Nigel Parker, who is noted for handling strategic collaborations and M&A deals for pharmaceuticals and biotechnology clients. Bespoke in-house technology tools such as the A&O Collaborate platform — which senior associate Zoe Grant advised on the development of — assist with multijurisdictional patent coordination projects. Marc Döring has retired from the firm.

Practice head(s):

David Stone; Jim Ford

Other key lawyers:

Neville Cordell; Mark Heaney; Mark Ridgway; James Fox; Marjan Noor; Rafi Allos; Nigel Parker; Zoe Grant

Testimonials

I can say without hesitation that Allen & Overy should undoubtedly be listed amongst the top three firms in this category. They have a whole suite of young, hard-working and strategically astute partners who have lifted the firm to the summit of IP litigation in this country.

Mark Ridgway – A class act from start to finish and everything in between. From initial advice through to conclusion of the trial, Mark should be your first port of call for any patent litigation.

Neville Cordell – An extremely sophisticated and astute lawyer.

Mark Heaney – Combines his incredible technical knowledge with a ferocious appetite to ensure the best outcome for his clients. You want Mark on your side for any high-tech litigation, you definitely don’t want him against you.

James Fox – Bright, extraordinarily charming and tactically astute. An outstanding associate who is destined not to be one for much longer!

The outstanding features of Allen & Overy are its multidisciplinary capabilities on an international scale.  A&O really do have direct access to specialists in all areas of the law on an international scale. This makes the firm outstanding in handling cases which have an international dimension and/or those which engage a range of legal issues outside of TMT/IP.

Marjan Noor is a stand out partner. She gets very involved in the case and manages at the right level. She is also very good at providing realistic budgets, which is refreshing and helpful for in-house counsel.

Key clients

Airbus

Bayer

Eli Lilly

GlaxoSmithKline

Huawei

Liberty Global

Regeneron

Samsung

Zimmer Biomet

Work highlights

  • Represented MGI Tech in patent infringement proceedings relating to six patents in the UK.
  • Represented Huawei in relation to Conversant’s claim for a declaration that it has offered “fair, reasonable and non-discriminatory” terms in respect of its standard essential patent portfolio.
  • Advised Eli Lilly on the first ever patent action in which the court allowed a claim to proceed in the UK seeking cross-border declarations of non-infringement (in six countries including the UK) alongside a UK patent revocation action.

Bird & Bird LLP

Bird & Bird LLP ‘s extensive experience on the life sciences side has seen the team successfully conduct patent infringement proceedings relating to ventilation technology though the expertise of Morag Macdonald and Eleanor Root, while transactional IP experts Sally Shorthose and Tom Snaith have handled a steady stream of patent licensing and M&A due diligence work for biotechnology clients. Neil Jenkins provides expertise on supplementary protection certificates. Both innovator and generics pharmaceuticals clients appear on the client roster. With a strong engineering background, co-head Katharine Stephens is sought out for complex litigation concerning mechanical technology, whereas fellow co-head Robert Williams is currently engaged in an aerospace dispute before the Intellectual Property Enterprise Court  (IPEC). Jane Mutimear and Richard Vary are key names for Standard Essential Patent (SEP) and FRAND litigation. Partner Christopher de Mauny also impresses in the hi-tech space.

Practice head(s):

Katharine Stephens; Robert Williams

Other key lawyers:

Morag Macdonald; Eleanor Root; Sally Shorthose; Tom Snaith; Neil Jenkins; Jane Mutimear; Richard Vary; Christopher de Mauny; Jenny Jones; Jae Park

Testimonials

The team is good at learning about and understanding our industry. They give good and honest advice, taking into account practicalities (not just esoteric legalities and possibilities).

Morag Macdonald – very experienced, and gives blunt but honest (and trusted) advice. Good at strategy in positioning case before the court and thinking several steps ahead.

Practical, knowledgeable, collaborative.

Seasoned experts with good working knowledge of the technology industry.

‘Morag Macdonald knows patent law and understands patent litigation like no other. She always gave us the comfort that our case was in very capable hands.’

Key clients

Allergan

Anheuser-Busch InBev

Canon

Ericsson

Fisher & Paykel

Honeywell International Inc

Johnson Matthey

Nokia

Sisvel International

Teva Pharmaceuticals

Work highlights

  • Successfully acted for Fisher & Paykel Healthcare against Flexicare relating to breathing circuits used in mechanical ventilation of patients.
  • Acting for Anheuser-Busch InBev, the world’s largest brewing company, in its defence of UK High Court patent revocation proceedings commenced by Heineken in relation to two of the client’s European patents relating to polymer packaging technology.
  • Acting for Mitsubishi and Sisvel in a UK High Court claim against multiple defendants for a declaration that the terms and conditions of the licence agreement offered by Sisvel to its mobile communication program (MCP) patent pool are fair, reasonable and non-discriminatory (FRAND) or, alternatively, a determination by the Court of the FRAND terms for the licensing of the patents in the MCP pool.

Bristows LLP

Bristows LLP fields one of the most extensive patent litigation benches in Europe, housing impressive names including co-heads Andrew Bowler and Myles Jelf ('Absolutely exceptional. Hugely experienced in international patent litigation'). Other key names include Dominic Adair, 'brilliant tactician' Brian Cordery, Liz Cohen, Robert Burrows and Gemma Barrett. Life sciences is a focus, however the technical backgrounds of the 'exceptionally smart' James Boon, Richard Pinckney, associate Naomi Hazenberg and others are also applied to disputes in the telecoms, aerospace and renewable energy sectors. The transactional offering led by Matthew Warren (who runs high-value licensing agreements in the life sciences and technology sectors) continues to expand: Richard Dickinson and numerous associates joined from Arnold & Porter, further strengthening the life sciences expertise. Also a highly regarded patent transactions lawyer, Claire Smith is a leader in the field of DNA-sequencing technology. The team advised on the University of Oxford’s landmark R&D agreement with AstraZeneca to manufacture and commercialise a Covid-19 vaccine.

Practice head(s):

Andrew Bowler; Myles Jelf; Matthew Warren

Other key lawyers:

Dominic Adair; Brian Cordery; Liz Cohen; Robert Burrows; Gemma Barrett; James Boon; Richard Pinckney; Naomi Hazenberg; Richard Dickinson; Claire Smith; Greg Bacon; Rachel Mumby; Matthew Raynor

Testimonials

Bristows remains top tier and for good reason. They are all accomplished litigators with a particular strength in life sciences cases. The individuals live and breathe their subject matter, know the industry inside out and are supported by their excellent regulatory and competition colleagues, which helps them stand out in global pharma litigation.

Probably the best UK-focused IP and TMT firm around The outstanding quality of both partners and associates is second to none.

Brian Cordery deserves all of the accolades he gets. A brilliant lawyer and tactician, and always prepared to roll up his sleeves and get stuck in to the detail of the legal work when needed. Amy Cullen is a future star (if she isn’t one already)- clever, great at drafting and unfailingly calm and pleasant to work with, even under pressure.

Myles Jelf is absolutely exceptional. Hugely experienced in international patent litigation, including working for some of the biggest names in the TMT sector, and with a very strong technical background, he is an amazing asset at the head of a litigation team.

Richard Pinckney has a wealth of legal and technical experience; bringing pragmatic and cost-effective solutions to the most complex of litigation problems he repeatedly delivers top-rate results for household-name international corporations.

Brian Cordery and Andrew Bowler are excellent – astute litigators as well as approachable and client-friendly. Matthew Raynor and Gemma Barrett have also impressed me greatly.

James Boon – Exceptionally smart. Great to work with.

Key clients

Novartis

ZTE

Philips

Google

Johnson & Johnson

University of Oxford

McDonalds International Property Company

Sony Interactive Entertainment Europe Ltd

Louis Vuitton Moet Hennesy

Genomics England

Heineken

Samsung

Siemens

University College London

Work highlights

  • Negotiated the covid-19 vaccine deal with AstraZeneca on behalf of University of Oxford.
  • Coordinated global action in the enforcement of patents for Novartis’ blockbuster medicines.
  • Representing Heineken, settled a revocation claim and defence of infringement involving three patents between the world’s two largest brewers, relating to counter-top polymer beer kegs.

Hogan Lovells International LLP

In a boost to Hogan Lovells International LLP’s London patent transactions capabilities, the firm recruited Joel Smith, former practice head at Herbert Smith Freehills LLP. Strengths include R&D, collaboration and licensing deals across a broad range of sectors from pharmaceuticals and genetics to mining. The impressive litigation bench includes esteemed practice head Paul Brown, Stephen Bennett, Daniel Brook and Katie McConnell. The team has coordinated expansive, cross-border patent litigation for a number of life sciences innovators working on vaccines and anaemia treatments, with assistance from counsels Stella Wong and Emma Fulton. With a reputation for conducting highly technical FRAND litigation in the telecoms sector and elsewhere, Bennett recently led on an innovative patent infringement case relating to beauty product formulas. Displaying broad sector strength, the team also defended an infringement action relating to engineering technology in the aerospace sector.

Practice head(s):

Paul Brown

Other key lawyers:

Stephen Bennett; Daniel Brook; Katie McConnell; Stella Wong; Emma Fulton

Key clients

Merck Sharp and Dohme (MSD)

Akebia Therapeutics

Eli Lilly

HTC

Vodafone

Solvay

Olaplex

Astronics AES

Work highlights

  • Successfully represented Olaplex, an innovative Californian start up, in a patent infringement case against L’Oréal.
  • Successfully represented Akebia Therapeutics in a three-way court battle before the UK High Court over anaemia treatments.
  • Secured an important victory for HTC against IPCom in a long-running patent litigation battle.

Powell Gilbert LLP

Indicative of the cutting-edge patent litigation handled at boutique firm Powell Gilbert LLP, Simon Ayrton, Zoë Butler and recently made-up partner Tom Oliver are currently leading a global dispute in the field of automated warehouse technology on behalf of FTSE 100 company Ocado Group. The team has considerable experience in the life sciences sector: practice head Penny Gilbert capably conducts pan-European litigation for biosimilar companies; Siddharth Kusumakar uniquely acts for both pharmaceutical innovators and generics companies; and Bethan Hopewell acts on significant disputes concerning medical devices. In other headline-grabbing litigation, Alex Wilson, Peter Damerell and Tim Whitfield lead a team defending Philip Morris International in a global patent infringement action against its smoke-free tobacco products. A number of team members field expertise in FRAND litigation, including Ayrton, Butler and Ari Laakkonen. Senior associate Tess Waldron also impresses in hi-tech patent litigation.

Practice head(s):

Penny Gilbert

Other key lawyers:

Simon Ayrton; Zoë Butler; Tom Oliver; Siddharth Kusumakar; Bethan Hopewell; Alex Wilson; Peter Damerall; Tim Whitfield

Testimonials

The firm has exceptional breadth of experience and technical know-how – both legally and in the TMT sector. there are very few firms in the UK which have the breadth of experience and quality of personnel. Quite simply – you cannot go wrong instructing Powell Gilbert and they will work exceptionally hard and with considerable talent and expertise to secure the best outcome for their clients.

Simon Ayrton, Zoe Butler and Alex Wilson are exceptional in the TMT area and have acted for some of the largest players in this sector. Ari Laakkonen has a wealth of technical and industry experience.

Penny Gilbert and Tim Powell are amongst the very best patent litigators, particularly in life sciences. But, frankly, their strapline that everyone there is excellent is pretty much accurate.

Powell Gilbert are one of the leading firms in the telecoms IP litigation market. They are one of the very best specialist technical patent firms in this area but also have an exceptional broader commercial understanding of the field and are one of the very best firms for FRAND litigation.’

Simon Ayrton is an incredibly astute and considered litigator with a track record in the biggest cases.

Zoë Butler is a brilliant team leader and superb with clients.

Tim Whitfield, one of the younger, but already very experienced partners is very knowledgeable in all issues of patent litigation. Tom Oliver, one of the latest additions to the partnership is very client orientated and will find a good solution to any problem the clients might have.

Key clients

Philip Morris International

Ocado Group plc

Huawei Technologies Co., Ltd.

Kymab

Edwards Lifesciences

Illumina, Inc

GSK

Coloplast A/S

Xiaomi

Lenovo Technology

BioNTech

Biogen

HEVC Advance LLC

CommScope

Promptu

Royalty Pharma

AIM Sport Vision AG

Actavis

St Gobain

Oxford University Innovations

NuCana

Work highlights

  • Defending UK biotechnology pioneer Kymab against Regeneron in the Supreme Court.
  • Represented Huawei in its high-stakes SEP litigation with Unwired Planet.
  • Representing Philip Morris International, leaders in the “heat-not-burn” tobacco sector with its IQOS system, in patent revocation actions against British American Tobacco.

Gowling WLG

Gowling WLG’s IP practice provides representation in patent litigation spanning the life sciences, technology and engineering sectors. Alexandra Brodie is recognised for handling SEP and FRAND litigation for cutting-edge telecoms clients, while in the pharmaceuticals sector, Paul Inman takes the lead on infringement and opposition proceedings, including ongoing instructions against world-leading generics companies relating to copycat insomnia treatments. In Gordon Harris, the team has a highly experienced High Court litigator for technically complex automotive, aviation and electronics patents. Primarily focused on the life sciences sector, Patrick Duxbury and Luke Kempton are the go-to names for patent licensing, collaboration and R&D negotiations. The dedicated medtech team includes notable partners Huw Evans and Jon Ball.

Practice head(s):

Kate Swaine

Other key lawyers:

Alexandra Brodie; Paul Inman; Gordon Harris; Patrick Duxbury; Luke Kempton; Huw Evans; Jon Ball

Testimonials

They are able to quickly assemble a diverse team with all skills necessary to deal with complex matters, namely litigation.

Huw Evans and Gordon Harris are outstanding patent litigators with huge experience of the patent courts.

‘Gowlings WLG has a first rate patent litigation team. Well organised and resourced, providing sound, clear legal advice. Client focused with huge experience of the practicalities of conducting complex patent litigation. Very commercial outlook. Able to work effectively with patent attorney firms providing technical support.’

Very hands-on, pragmatic and down to earth people. Ahead of developments. I love Kate Swaine!’

‘Huw Edwards is a very experienced litigator. Jon Ball is easy to work with: commercial and down to earth. They’re both clearly dedicated and hard working patent litigators.’

Key clients

InterDigital

Neurim Pharmaceuticals

Oatly AB

Comcast/Sky

Aston Martin Lagonda

Kingspan

Hextatronic Group

Freddy SpA

AstraZeneca

Sosei Heptares

Work highlights

  • Acting for interDigital in FRAND litigation against Lenovo Group.
  • Acting for Neurim in a UK dispute with Generics UK (t/a Mylan) concerning Mylan’s proposed generic copy of Neurim’s highly successful melatonin product, Circadin.
  • Defending Hexatronic Group — a global leader in fibre optic cable technology — in proceedings relating to the design of thermoplastic outer sheath coatings of fibre optic cables for the purposes of blowing fibre installation.

Herbert Smith Freehills LLP

The contentious IP bench at Herbert Smith Freehills LLP in London includes highly rated litigators Sophie Rich (who jointly leads the global practice), Sebastian Moore, Andrew Moir and senior associate Andrew Wells. Market-leading pharmaceuticals innovators and medtech corporates instruct the firm on multijurisdictional oppositions and patent infringement proceedings, including recent precedent-setting matters relating to the doctrine of equivalents. The team receives commercial IP instructions, which are typically handled by Jonathan Turnbull (following Joel Smith's departure to Hogan Lovells International LLP), who applies his scientific background to the global commercial aims of blockbuster medicinal products, often in collaboration with the firm’s extensive European network. Senior associate Emily Bottle has extensive knowledge in the law around genetic diagnostics and DNA sequencing.

Practice head(s):

Sophie Rich

Other key lawyers:

Sebastian Moore; Andrew Moir; Andrew Wells; Jonathan Turnbull; Emily Bottle

Testimonials

Very good experienced litigation team with strength in depth.

Herbert Smith Freehills have an extremely strong team in the life sciences patent sector and in my view rank amongst the best in that field.

Sebastian Moore has the ability to lead the team and see the big picture yet also grasp the detail; he is astute and thoughtful.

Andrew Wells has particularly impressed me.

Key clients

Ariosa Diagnostics Inc.

Gilead Science, Inc., Gilead Sciences Ireland UC and Gilead Science Limited

CSL Behring

Millennium Pharmaceuticals

Sky UK Limited

Genentech, Inc.

Unilever

Chugai Pharmaceutical Co Ltd

Biogen Inc.

Sanofi-Aventis

Work highlights

  • Representing Ariosa Diagnostics, following a patent infringement action brought by Illumina and Sequenom in relation to EP’963. Illumina and Sequenom brought another patent infringement action alleging that the Harmony Test infringes an additional patent (EP’321).
  • Representing Gilead in UK proceedings and advising on and coordinating Gilead’s response to parallel proceedings brought by ViiV in a number of other EPC jurisdictions. The proceedings relate to Gilead’s HIV integrase inhibitor, bictegravir (which forms part of Gilead’s anti-HIV regimen BIKTARVY®).
  • Advising Sky in defending patent infringement litigation relating to an advertising data-collection system.

Kirkland & Ellis International LLP

The patent litigation practice at Kirkland & Ellis International LLP continues to secure impressive mandates in the life sciences sector through the reputation of practice head Nicola Dagg. With support from Katie Coltart and Jin Ooi, the firm has represented biotechnology innovators in significant transatlantic patent infringement proceedings before the Supreme Court. Steven Baldwin and associates Peter Pereira and Gabriella Bornstein have expertise in SEP and FRAND litigation for international telecoms and technology clients. A team of transactional IP lawyers is able to advise on M&A due diligence, licensing negotiations and joint ventures for global clients in the hi-tech industries.

Practice head(s):

Nicola Dagg 

Other key lawyers:

Daniel Lim; Katie Coltart; Jin Ooi; Steven Baldwin; Peter Pereira; Gabriella Bornstein

Testimonials

Nicola Dagg is one of the leading IP partners in the market.

Jin Ooi is very effective and extremely responsive.

The Kirkland & Ellis team offers broad-based skills throughout its experience range. Bright, insightful analysis is assured – delivered with appropriate reverence and humor.

Nicola Dagg is the genuine article. Experienced, smart, ever-prepared, thoughtful, and well informed beyond the immediate task/case at hand.

Daniel Lim is devoted to delivering thorough and thoughtful analysis and work product. The work product speaks for itself.

Steven Baldin is a pleasure to work with. He is fantastic both in his grasp of the detail and clear strategic thinking. High customer focus. Attention to detail and prepared to think outside the box.

Peter Pereira – High expertise, Excellent work commitment, dedication to case, prepared to consider novel approaches to achieve practical goals.

The team has developed novel, cutting-edge and coordinated global strategies which play out in litigation across the world, including China.

Katie Coltart is incredibly responsive and astute. A real pleasure to work with.

Key clients

British American Tobacco

Lenovo

Samsung

Alcon

Abbott

Xiaomi

Regeneron Pharmaceuticals

Bayer

Autostore

Pfizer / Viatris

Novartis

Meril Life Sciences

TCL Corporation

Adaptive Spectrum and Signal Alignment Inc. (ASSIA)

BBC Studies & Britbox

Sonova

Work highlights

  • Represented Regeneron in its complex and hard-fought patent litigation against Kymab, which went all the way to the UK Supreme Court.
  • Representing AutoStore, a global leader in robotics and pioneer of warehouse automation systems, in a cross-Atlantic multi-patent infringement dispute commenced against Ocado Group.
  • Representing Lenovo/Motorola Mobility in proceedings resulting from a major SEP/FRAND worldwide licensing dispute between InterDigital and Lenovo/Motorola Mobility, with parallel proceedings in the UK, the US and China.

Marks & Clerk

Marks & Clerk’s head of life sciences Mike Gilbert is known for defending large companies in the biotechnology, pharmaceuticals and chemicals sectors in patent revocation litigation, often working with Charlie Balme and Trevor Crosse. Leading the hi-tech patent litigation practice, Dafydd Bevan handles infringement litigation in the electronics, software, telecoms and mechanical sectors. Graham Burnett-Hall also receives highly technical mandates, recently in the automotives sector. The commercial IP offering spearheaded by Michael Moore advises on collaboration agreements, licensing deals and M&A due diligence.

Practice head(s):

Mike Gilbert; Michael Moore; Dafydd Bevan

Other key lawyers:

Charlie Balme; Trevor Crosse; Graham Burnett-Hall

Testimonials

‘They thoroughly explained special aspects of British law. They keep up to date in recent court decisions and apply them to the current case where appropriate.’

‘Graham Burnett-Hall quickly reaches a good understanding of the technology and discusses the core problems in detail. He is also good at predicting and explaining the legal assessment.’

‘Very experienced and respected team, very good value for money, well able to handle technically and legally complex cases, pragmatic, great knowledge of the pharma industry, great team work, work well with firms in other jurisdictions, transparent, open to dialogue, always responsive.’

‘Mike Gilbert is very experienced and respected, capable of handling legally and technically complex cases. He is pragmatic and sees the whole picture when providing legal advice, has a really good knowledge of the pharma/life sciences industry, and stays calm under pressure. He is client oriented, and transparent and open to discussion about case management, resource allocation etc. A great team leader.’

‘Graham Burnett-Hall is excellent. He really understands the scope of our patents and explains the legal issues clearly and practically. He is very responsive and helpful.’

Key clients

Pfizer

Genentech

H. Hoffmann-La Roche

Daiichi Sankyo

The Broad Institute

dSPACE

Manitou

Work highlights

  • Advised Pfizer in patent litigation proceedings against Merck Sharpe & Dohme in relation to Pfizer’s multibillion-dollar Prevenar 13 vaccine.
  • Advised Genentech in patent litigation proceedings against Eli Lilly in relation to Lilly’s multibillion-dollar Taltz product.
  • Advised Manitou in patent litigation proceedings against JCB.

Pinsent Masons LLP

With Clare Tunstall at the helm, Pinsent Masons LLP's IP practice is a market leader for patent revocation litigation in the life sciences sector and is often instructed by major international generic pharmaceuticals companies. The 'top-notch partner' Charlotte Weekes and the 'very commercially savvy and exceptionally bright' Christopher Sharp are also highly active, having recently provided representation in High Court proceedings relating to high-value blockbuster drugs. Showcasing expertise in cutting-edge transactional mandates, Allistair Booth and Nicole Jadeja (whose practice cuts across contentious and non-contentious work) advised the UK Government on its agreement with Pfizer and BioNTech for the world-first supply of the Covid-19 vaccine. Catherine Drew is another highly praised litigator.

Practice head(s):

Clare Tunstall

Other key lawyers:

Charlotte Weekes; Christopher Sharp; Allistair Booth; Nicole Jadeja; Catherine Drew; David Lancaster

Testimonials

The team really offers the full package. They are brilliant to work with, bright and resourceful.

Christopher Sharp is a phenomenal asset to the firm. He is incredibly user friendly, very commercially savvy and exceptionally bright.

Catherine Drew is very strong. She is very commercially aware, and has a fantastic understanding of the legal arguments and how they sit with the facts.

Normal people who are also excellent lawyers, with a particular strength in pharmaceutical patents. Highly diverse team, with significant number of female partners.

Charlotte Weekes – top-notch partner, who really has her eye on the client’s commercial objectives.  Lots of experience in pharmaceutical patents, a great eye for detail and a pleasure to work with.

David Lancaster brings extensive litigation experience in information technology and biopharma, but more than this, he is excellent in managing the client relationship. He is able to listen to different points of view and converge on the optimum strategy.

Pinsent Masons has a really strong team with good strength in depth. Their partners are astute and commercial and their associates clever and diligent. They are particularly good at collaborating to deal with cases efficiently.

Key clients

Her Majesty’s Government

Teva Pharmaceutical Industries Limited

ZyXEL Communications UK Limited, ZyXEL Communications A/S

Safran Seats GB Limited

Accord Healthcare

Flynn Pharma Limited

RedX Pharma

4D Pharma

Evgen Pharma Plc

Imcyse

JUUL Labs Inc

Work highlights

  • Acted for the UK government on its agreement with Pfizer and BioNTech for the supply of a vaccine against Covid-19.
  • Represented Teva UK in a claim to revoke Janssen Pharmaceutica NV’s SPC in respect of Janssen’s Xeplion product. Xeplion is an intramuscular injectable formulation of paliperidone which is also available in oral form – both are for the treatment of schizophrenia.
  • Advising Flynn Pharma in proceedings against Mylan with co-claimant and patentee, Neurim. The dispute concerns Neurim’s patent covering prolonged-release melatonin formulations for use in treating insomnia marketed under the product name Circadin.

Simmons & Simmons

The 'first-class’ IP practice at Simmons & Simmons fields a strong bench of contentious and non-contentious experts with a high degree of experience and knowledge in the life sciences and technology sectors. Team head Michael Gavey is a go-to name for commercial IP work, acting on impressive patent transactions, in particular for big-name pharmaceuticals corporates. Also in the non-contentious space, Angus McLean maintains a reputation in the fintech sector. Stand-out litigators include Michael Burdon, the 'enormously experienced and commercial' Scott Parker and Andrew Hutchinson, who receive mandates from a broad roster of biosimilar, healthcare, medical devices, telecoms and engineering clients.

Practice head(s):

Michael Gavey

Other key lawyers:

Angus McLean; Michael Burdon; Scott Parker; Andrew Hutchinson; Priya Nagpal; Lydia Torne; Christina Thompson

Testimonials

Priya Nagpal is my go-to person at Simmons & Simmons. Priya combines incredible technical knowledge with thoughtful, commercial solutions to our IP problems. Priya is also supported by an excellent team in other areas outside of IP, for example data protection issues.

The team we are working with in pharma patent litigation is impressively committed, efficient, responsive and competent, both with regard to legal strategy and the science/technology at issue, and is always on top of all the issues. The feeling of having your case in excellent capable hands at all times is priceless. Also their proactive budget tracking is very much appreciated.

Andrew Hutchinson is an extremely quick thinker with a great strategic mind and an understanding of the needs of an industry client- not the least with regard to budget management which is becoming ever more important.

‘Lydia Torne is an excellent lawyer with a thorough understanding of our business and the life science and healthcare industry in general.

Michael Gavey’s transactional IP knowledge is second to none. We have also worked closely with Christina Thompson and found her extensive patent knowledge and life science background to be very valuable.

Scott Parker is an excellent litigator. Great attention to detail and clients seem to trust him wholeheartedly with their critical business issues. On top of that he is thoroughly decent and a pleasure to work with. Michael Burdon is a legend. With many years before the UK courts under his belt he is a seasoned and highly effective litigator.

An excellent team with phenomenal technical and litigation ability. A real first-class outfit.

Scott Parker is enormously experienced and commercial. Andrew Hutchinson has a great grasp of detail and fights every last corner for client.

Key clients

AIXTRON

Insulet

AB Electrolux

Acelity

Alzheimers’ Research UK

Apple

Ascendis Pharma

Bayer HealthCare LLC

Bose Corporation

Boston Scientific Corporation

Genmab A/S

Gilead

GlaxoSmithKline

Google – DeepMind Technologies

Guangdong OPPO Mobile Telecommunications Corp., Ltd

Mitsubishi UFJ Trust & Banking Corporation

OGCI CI LLP

Oxford University

Roland Europe

Samsung Bioepis

TCL

The Institute for Cancer Research

UCB Pharma

ViiV Healthcare

Work highlights

  • Acting for UCB on the launch of its important anti-IL-17 product bimekizumab for the treatment of psoriasis and other inflammatory diseases, including revocation actions and EPO opposition in respect of a Genentech patent.
  • Defending Gilead in a spate of SPC revocation actions brought by numerous generics clients.
  • Representing Samsung Bioepis in biosimilar patent litigation concerning an adalimumab formulation patent held by Gedeon Richter.

Taylor Wessing LLP

The expansive patent litigation bench at Taylor Wessing LLP includes UK practice head Nigel Stoate, international practice head Simon Cohen and hi-tech expert James Marshall. The team has recently been involved in high-profile work relating to patent revocation actions for generic pharmaceuticals companies. In other highlights, Christopher Thornham successfully defended non-infringement declarations in the consumer electronics sector. The additions of Adrian Toutoungi from Eversheds Sutherland (International) LLP and Alison Dennis from Fieldfisher further strengthen the non-contentious partner bench, which also includes Colin McCall and regulatory expert Tasmina Goraya. Typical work includes licensing, manufacturing and collaboration agreements in the medtech and life sciences sectors.

Practice head(s):

Nigel Stoate

Other key lawyers:

Simon Cohen; James Marshall; Christopher Thornham; Adrian Toutoungi; Alison Dennis; Colin McCall; Tasmina Goraya

Testimonials

This team combines a high level of domain expertise in biotech, along with great knowledge of current commercial norms. They also provide a high-value service at a very reasonable price for early-stage companies.

Colin McCall has been exceptionally supportive of our business. He is always responsive, even when he is away from his desk. He is very knowledgeable of biotech, the commercial landscape and the law. He offers flexibility on fees as he recognises our stage and is looking to build a long-term relationship. I enjoy working with him as well.

Key clients

Oppo

Lupin

Ericsson

Glenmark Pharmaceuticals

ASUS

Shenzhen Senior Technology Materials Ltd

Mylan

NOCO

Work highlights

  • Defending OPPO and OnePlus in patent infringement proceedings concerning 3G and 4G technology brought by Mitsubishi and Sisvel.
  • Represented Lupin against Chiesi Farmaceutica seeking revocation of two patents regarding its combination inhaler product (branded Fostair) for treating asthma, to clear the way for a Lupin product launch in the UK.
  • Advised on the divestment of Glenmark Pharmaceuticals’ established portfolio of central nervous system (CNS) products in Poland. This involved complex IP issues including the assignment and licence of IP rights, regulatory dossiers and marketing authorisations.

Baker McKenzie

Baker McKenzie’s IP practice is highly active in the life sciences and technology sectors, driven by the expertise of the 'very bright, technically strong and very responsive' practice head Hiroshi Sheraton and 'stand-out' associate Tanvi Shah. Global pharmaceuticals, cosmetics and medical devices companies instruct on high-stakes patent litigation, with recent mandates involving complex chemical formulas of consumer products. The team advises on international litigation strategy concerning patented technology in the heavy equipment industry. In the commercial sphere, clients in the energy sector are currently instructing the team on multibillion-pound joint ventures.

Practice head(s):

Hiroshi Sheraton

Other key lawyers:

Tanvi Shah; George Khouri; Gemma Jones-Parry

Testimonials

Provide clients with an excellent, Rolls Royce service which is what one goes to them for. They have demonstrated during the pandemic that their use of remote working is top class and their operation so far as I have observed has been essentially unaffected.

Hiroshi Sheraton is an outstanding individual in the field and I would (and have in the past) unhesitatingly recommend his services. George Khouri and Gemma Jones-Parry are top notch, self-motivating, with great initiative and sense.

The team is very approachable and understands the level of detail the client wants from the advice sought. The advice is easy to understand and not full of legal jargon. The team is highly skilled at all aspects of IP law around patents, particularly in relation to the pharma, biotech and life sciences areas. The advice is pragmatic and solution orientated which the management team can easily digest and rely upon.

Hiroshi Sheraton is very personable, approachable and his advice is detailed and sensible. Hiroshi’s advice is very commercially focused – he has a good understanding of the pressures within a company and knows what is needed from the advice sought.

The team is led by the excellent Hiroshi Sheraton who is very bright, technically strong and very responsive. Other stand out lawyers in his team are Tanvi Shah and Gemma Jones-Parry.

Friendly, approachable and helpful.

The Baker McKenzie patents team is one of best in the UK market and not only complements the other parts of the firm, but is in its own right a very high-quality litigation team. I would highlight the added value of the cross-border strategy and service that Bakers is able to provide.

Key clients

CSL/Seqirus

Eli Lilly

GSK

Hitachi

JCB

L’Oréal

Novartis

Novo Nordisk

Work highlights

  • Representing L’Oréal in a complex global patent dispute with US company Olaplex in connection with a patent that is alleged to cover L’Oréal’s Smartbond product.
  • Representing JCB in a claim for infringement of five patents relating to safety systems applied to telescopic handlers, against French competitor Manitou. The case is complex with numerous interim matters having been appealed to the highest level.
  • Advising a global pharmaceutical company on a pan-European basis in relation to the defence and enforcement of its portfolio of several patents covering combination products, formulation patents, second medical uses and treatment/dosage regimens against a threatened launch and challenge by a generic pharmaceutical company.

CMS

Primarily operating within the life sciences sector, CMS’ patent litigation offering is noted for running high-profile litigation for international generic pharmaceuticals companies. Highlight engagements saw practice co-head Gareth Morgan and newly made-up partner Sarah Innes initiate SPC revocation trials through the High Court. Sandoz recently instructed on significant damages claims though the Patents Court. Co-head Sarah Hanson has a non-contentious focus, including complex patent rights transfers. Caitlin Heard is an active litigator in the telecoms and construction sectors.

Practice head(s):

Sarah Hanson; Gareth Morgan

Other key lawyers:

Sarah Innes; Caitlin Heard

Testimonials

Easy to deal with, very transparent with fees and good litigators.

Caitlin Heard provided an excellent service. She has a formidable knowledge of the subject area but is also highly practical and an astute litigator. Very transparent over fees too, with regular updates and always delivered the work within the estimate.

Key clients

Sandoz

Estar

ARM/Gemalto

Teva

Work highlights

  • Acting for Teva in a patent and SPC revocation action against Sanofi.
  • Launched a revocation action on behalf of Sandoz against Astellas concerning Mirabegron, a pharmaceutical compound used to treat conditions in which the bladder is unstable or overactive.
  • Acting for Sandoz in the multi-applicant and highly complex damages claim against Warner-Lambert in relation to its wrongly granted injunction in the Pregabalin patent infringement proceedings.

EIP

As a prolific name in the field of FRAND litigation, EIP’s patent litigation practice is regularly instructed by leading electronics and telecoms companies on the highest profile Supreme Court trials. With the 'strategic mastermind' Gary Moss heading the team and Robert Lundie Smith, Matthew Jones, Andrew Sharples and Kathleen Fox Murphy fleshing out the partnership, the bench is suitably broad enough to handle highly technical and demanding litigation. In the life sciences sector, Jones’ biotechnology expertise is applied to renovation actions concerning blockbuster drugs.

Practice head(s):

Gary Moss

Other key lawyers:

Robert Lundie Smith; Matthew Jones; Andrew Sharples; Kathleen Fox Murphy

Testimonials

They keep winning. In the end, that’s all that really matters.

The EIP team have unparalleled experience in the heaviest of telecoms litigation, having run or been involved in virtually every leading patent case in that area in the past five years. They are incredibly easy to work with, responsive and strategically excellent.

Gary Moss is the strategic mastermind behind the whole FRAND industry in the UK, and has unparalleled experience in this area. Very bright and hard working too, he has an excellent rapport with clients and an ability to understand and pre-empt their commercial needs and concerns. Robert Lundie-Smith has an excellent technical understanding, and an eye for details which makes him a leading choice for technical patent actions. He works unceasingly to push forwards the strategically and tactically best possible case.

I highly recommend Robert Lundie Smith. He is very hardworking, conscientious, and has a real understanding of the technical, legal and strategic aspects of the cases he is working on.

Key clients

Conversant

Teleste

Unwired Planet

Optis

Vestel

Godo Kaisha IP Bridge 1

Work highlights

  • Secured a landmark victory in the Supreme Court in the sphere of FRAND litigation for Unwired Planet International Limited and Conversant Wireless Licensing.
  • Represented Conversant Wireless Licensing in highly complex standard essentially patent litigation involving three of the client’s patents.
  • Represented Optis Cellular Technology before the High Court in technically complex patent litigation against Apple.

Linklaters LLP

Linklaters LLP’s IP team provides capabilities across contentious and transactional patent instructions. Nemone Franks regularly advises on cross-border M&A transactions and technology transfers in IP-rich sectors, while Yohan Liyanage negotiates patent licensing agreements in the telecoms and pharmaceuticals sectors. Liyanage and practice head Ian Karet have a reputation for patent litigation in the healthcare sector, predominantly for global innovators. Ongoing proceedings relate to global infringement disputes concerning antibody technology and HIV  treatments.

Practice head(s):

Ian Karet

Other key lawyers:

Nemone Franks; Yohan Liyanage; Stephanie Farrington

Testimonials

The team is composed of extremely smart people who have the ability to analyse complicated issues. Their strength is in the interdisciplinary way of looking at things from various angles in order to find the most efficient solution for the matter.

Ian Karet brings a wealth of invaluable experience with him and is a major asset to any client embroiled in high-stakes patent litigation. He is clever, strategic, technically excellent and a pleasure to deal with.

Yohan Liyanage continues to grow a well-deserved reputation as a top patent litigator. He continues to be instructed on some of the best mandates which is testament to his talent and the confidence that clients have in him.

Stephanie Farrington is a rising talent at the firm. She is diligent, hard working and always a pleasure to deal with.

Ian Karet has a unique way of looking at things. He is also able to very quickly look at a set of complex facts and identify the key issues and succinctly describe and address them. I have not seen that talent elsewhere, at least not to the same extent. He is also quick to respond to any inquiries.

Key clients

GlaxoSmithKline

Sanofi

Regeneron Pharmaceuticals

Unilever

Takeda Pharmaceuticals

Novartis

Nestlé

BP

Bayer

Work highlights

  • Advising GlaxoSmithKline on a multijurisdictional European patent dispute relating to an HIV treatment.
  • Advising Sanofi and Regeneron on a multijurisdictional patent dispute relating to a monoclonal antibody treatment for cardiovascular disease.
  • Advising BP on the sale of its global aromatics and acetyls petrochemicals business to INEOS, including a very sizeable patent portfolio.

Mishcon de Reya LLP

Mishcon de Reya LLP’s ‘very dynamic and experienced‘ patents group attracts clients in the generic pharmaceutical industry, with practice head David Rose and Martyn Hann working on patent revocation actions and invalidity proceedings of SPCs. Hann also leads on commercial IP and patent licensing mandates. In a boost to the team’s capabilities in the technology sector, Helen Conlan joined from Bird & Bird LLP, bringing a wealth of litigation expertise in the field of standard essential patents. Jeremy Hertzog  and legal director Peter Nunn assist with patent infringement and entitlement cases in the telecoms sector.

Practice head(s):

David Rose

Other key lawyers:

Martyn Hann; Helen Conlan; Jeremy Hertzog; Peter Nunn; Campbell Forsyth

Testimonials

Mishcon de Reya continues to provide excellent patent services alongside the full spectrum of intellectual property rights in the context of a full-service firm.

David Rose is an extremely experienced practitioner who, unusually, operates across the full spectrum of intellectual property, enabling him to be the first port of call for all of a client’s intellectual property needs, and handle complex multi-faceted litigation involving multiple different rights.

Great speed and quality – the best combination they can provide. Real experts, which are ready to react promptly and professionally.

Very dynamic and experienced team. It provides practical solutions with an outstanding quality.’

‘Campbell Forsyth is a market-leading patent litigator with huge experience both in the pharmaceutical and telecoms sectors. He has an extraordinary eye for detail, whilst also being able to structure a case to maximise pressure and get the result which his client wants.’

‘Campbell Forsyth is always thinking several steps ahead, and able to caution well in advance of any pitfalls or traps. He is always keeping track of the numerous issues and questions to be resolved.’

Key clients

Dr Reddy’s Laboratories (UK) Limited

Top Optimized Technologies, S.L. and TOT Power Control, S.L.

Lupin Limited

Sky

Alternative Foods

Hotpod Yoga

Soterios

Work highlights

  • Representing DRL in a significant damages enquiry against Warner-Lambert in relation to its patent relating to pregabalin.
  • Advising Top Optimized Technologies SL and TOT Power Control on a substantial claim against Vodafone for patent infringement and breach of confidentiality, including in relation to a jurisdictional challenge.
  • Acting for Lupin relating to Gilead’s Supplementary Protection Certificate (SPC) for Truvada, found invalid by the Court of Appeal following a reference to the CJEU.

Osborne Clarke LLP

With  'IP celebrity' Arty Rajendra at the helm, Osborne Clarke LLP has a patent litigation practice sought out in the hi-tech space, particularly for high-stakes SEP and FRAND litigation. Will James is  retained by technology-driven multinationals for advice on litigation and more strategic commercial patent matters. Recently recruited from Bird & Bird LLP, Tim Harris adds to the existing life sciences expertise of James and 'stand-out' associate director Chris Pratt. The trio regularly handle litigation for high-profile biotechnology and pharmaceuticals clients.

Practice head(s):

Arty Rajendra

Other key lawyers:

Will James; Tim Harris; Chris Pratt

Testimonials

This is an excellent team that has top-flight clients. It has operated slightly under the radar until recently, quietly delivering huge litigation successes in important cases. That is changing and people are starting to see the Osborne Clarke crowd more and more – they are becoming difficult to fail to notice! The combination of a really friendly face with detail-oriented technical work makes for an excellent service and has delivered some astounding results.

Chris Pratt is a stand-out who has been vitally involved in some enormous pieces of litigation in recent years. He is surely destined for great success

Will James is a warm and thoughtful leader of a litigation team. He is always on top of the technical detail, and making excellent contributions to the right strategy, but at the same time clearly feels able to trust his team to an appropriate degree to allow the client’s money to be spent most efficiently. It is impressive to watch.

Arty Rajendra is rightly an IP celebrity in this jurisdiction; she has been involved in many high-profile cases for large and small clients. She fights hard, but thoughtfully, and deserves all of her considerable successes.

The group is up and coming and they are making their mark in the field with some recent high profile hires. I have worked with them in a major life sciences case and they are simply top notch.

Will James is an exceptional individual.

Key clients

Unwired Planet LLC

Optis

PopSockets LLC

Amgen Inc

Amphista Therapeutics

Work highlights

  • Advising Amgen in litigation strategy concerning the intensely competitive new clinical field of cholesterol-lowering (anti-PCSK9) antibodies for the treatment of cardiovascular disease.
  • Advising on a series of six technical and FRAND trials concerning standard essential patents for mobile phones (co-counsel for Optis with EIP).
  • Acted as co-counsel with EIP for Unwired Planet in a landmark case against Huawei concerning Standard Essential Patents and FRAND licensing.

Stephenson Harwood

Owing to its 'intelligent, easy to work with, hardworking, and responsive' IP team, Stephenson Harwood secures impressive non-contentious patent matters in the life sciences and energy sectors. Practice head Alexandra Pygall and Naomi Leach are key names for cross-border commercial licensing agreements and transactions, predominantly for pharmaceutical and biosciences innovators. Showcasing broader sector knowledge, a team led by Leach advised on patent and know-how licensing deals in the clean energy sector. Rob Jacob regularly runs patent litigation, having recently pursued infringement claims and commercial disputes through the Patents Court on behalf of shipping and security companies.

Practice head(s):

Alexandra Pygall

Other key lawyers:

Naomi Leach; Rob Jacob; Dan Holland

Testimonials

Stephenson Harwood’s TMT practice is a very collaborative and knowledgeable group of individuals who provide practical no-nonsense advice, make an effort to learn your business in order to anticipate problems, and are always accessible.

Everyone I’ve had the pleasure to work with has shown high work ethic, great interest in the issues posed, and pragmatism in addressing them. Dan Holland, Alexandra Pygall and Naomi Leach in particular have been fantastic!

The team has a deep understanding of the commercial aspects of the law. They seek to understand the business and its goals to enable the best results. They are also excellent at crystallizing legal issues in a way that makes a path forward clear.

The team is intelligent, easy to work with, hardworking, and responsive. We have worked with them on complex multinational projects. The team is always organised and has a terrific grasp and management of complex issues.

Alexandra Pygall: Excellent commercial advice; timely and practical advice to clients.

Key clients

GlaxoSmithKline plc

Oxford Biomedica

UCB

Kymab Limited

Acacia Pharma

Incyte Corporation

Novacyt A.S.

Highview Power

Shield Therapeutics

AM-Pharma

Lucozade Ribena Suntory

Work highlights

  • Advised Oxford Biomedica on the manufacture and supply of AZD1222, the adenoviral Covid-19 vaccine candidate developed by Oxford University and commercialised by AstraZeneca.
  • Advised Highview (a global leader in long-duration energy storage solutions), in relation to partnering with Sumitomo Heavy Industries (a technology leader in industrial machinery and environmental and power technologies) to expand cryogenic energy storage projects globally.
  • Advised Shield Therapeutics in relation to critical out-licensing of its patent rights in Europe and China in two separate but interlinked and complex deals.

Wiggin LLP

Wiggin LLP’s IP practice is lauded in the technology and media sectors, regularly securing sizeable mandates across the litigation and transactional disciplines. Both claimants and defendants instruct practice head Sara Ashby, Calum Smyth, Michael Browne and senior associates Victoria Gyles and Flora Greenwood on patent infringement, validity and enforcement actions in industries ranging from mechanical engineering and automotives to software and consumer electronics. Close collaboration with the growing Brussels office significantly boosts cross-border project capabilities.

Practice head(s):

Sara Ashby

Other key lawyers:

Calum Smyth; Michael Browne; Victoria Gyles; Flora Greenwood

Testimonials

Wiggin’s patent practice is one of the best in London. It is led by Sara Ashby who is one of the most exceptional litigators I have worked with. She has built an exceptional team.

Michael Browne is a very capable litigator in the fields of TMT matters with an IP element.

Key clients

Permavent Limited & Greenhill Industrial Holdings Limited

Hozelock

3M

MacGregor Healthcare

BPW Bergische Achsen KG

Tanks and Pipeworks Limited

Work highlights

  • Acted for the successful defendant, Hozelock, in a patent infringement and validity matter, invalidating a patent which had been previously litigated to the Court of Appeal and had a Certificate of Contested Validity.
  • Acted for the successful claimants Permavent Limited and Greenhill Industrial Holdings Limited in a long-running High Court patent entitlement dispute.
  • Currently acting for 3M in ongoing patent validity proceedings against Saint Gobain in the Patents Court.

WilmerHale

Cited for the strong collaboration between its UK and US offices, WilmerHale’s patent litigation practice is a go-to name for impressive, household-name technology giants. The London partnership consists of Trevor Cook, Matthew Shade, Anthony Trenton and 'heavyweight' Justin Watts, who are all engaged in high-profile, multibillion-dollar FRAND litigation. In the life sciences sector, the team is coordinating pan-European litigation for Bristol-Myers Squibb relating to a blockbuster drug. Also ongoing are parallel infringement proceedings relating to patented medical devices.

Other key lawyers:

Trevor Cook; Matthew Shade; Anthony Trenton; Justin Watts; Christina Guazzi; Annsley Ward

Testimonials

Justin Watts remains a heavyweight in the field – across the entire landscape of patents including life sciences, pharma and telecoms. His encyclopaedic knowledge of patent law, extensive litigation experience and polymath technical background ensure he remains head and shoulders above the competition.

Matthew Shade is a rising star particularly in the life sciences sector. Strong team leadership skills enable Matthew to coordinate complex litigation across multiple jurisdictions.

Christina Guazzi is diligent and exceptionally intelligent and  punches far above her weight.

They combine brilliance in legal knowledge with a practical commercial focus to create great strategic solutions for clients.

Annsley Ward is simply excellent. She is a phenomenal litigator and stands out for her technical prowess, strategic insight, and dedication to achieving the best outcome for her clients. On top of all that she is always available and an absolute pleasure to work with.

Anthony Trenton is a specialist intellectual property litigator with a very detailed understanding of the operation of the UK’s specialist intellectual property courts, which he regularly deploys to find precisely the right approach to best advance his client’s case.

First-rate team of highly experienced patent lawyers and some rising stars supporting them. Those that I have worked with have a double talent of both being top of their game as patent lawyers, and also very experienced in dealing with highly technical material which makes them extremely efficient in getting the best out of expert witnesses and draw out effective evidence.

Trevor Cook is one of the world’s top intellectual property advisors. Has a encyclopedic knowledge of intellectual property law and a serious commercial acumen for the best solution.

Key clients

Bristol-Myers Squibb

Work highlights

  • Advising Bristol-Myers Squibb in relation to litigation concerning its anticoagulant drug Eliquis, one of the highest revenue pharmaceuticals on the market.

Arnold & Porter

In a notable mandate for Arnold & Porter’s patents practice, commercial IP expert Ewan Townsend was part of a global team advising AstraZeneca on its manufacture and purchase agreements with the University of Oxford for the Covid-19 vaccine. Other non-contentious highlights pertained to multibillion-dollar product divestments in the pharmaceuticals sector. Practice head Beatriz San Martin leads on patent litigation, particularly in relation to SPCs in the life sciences sector.

Practice head(s):

Beatriz San Martin

Other key lawyers:

Ewan Townsend

Testimonials

Advice is always pertinent, specific and delivered in a timely manner.

Beatriz San Martin is skilled in all areas of IP and provides thoughtful, rounded advice. She identifies and responds to the client’s needs. I’m always happy to recommend her, because I know the client will be well looked after and very satisfied with the work she does.

One of Beatriz San Martin’s strengths is how she combines her excellent analytical skills and inquisitiveness, to provide tailored strategic advice to a particular problem or dispute. I am always impressed by the attention that Beatriz pays to client service and responsiveness, irrespective of the subject matter.

They work quickly and to an exceptionally high standard whilst also being collaborative and practical.

Beatriz San Martin and Ewan Townsend are both great. I value their straight-forwardness, and ability to navigate complex scenarios as reported on our previous telephone discussion.

The team is responsive, knowledgeable and pragmatic. What separates them from some of the other firms, is their ability to make their judgment with the specific business area in mind. Their views are balanced and tailored to their customers.

Their knowledge and expertise in the area of pharmaceutical products and medical devices is, in my opinion, more robust and broad than in cases of some of their competitors. They also demonstrate very strong commercial knowledge and understanding of the business. In a relatively niche area, that is extremely valuable.

Key clients

Sandoz

AstraZeneca

Pfizer

Bristol-Myers Squibb (BMS)

Clovis Oncology

Norgine

The Association of the Cannabinoid Industry (ACI)

Cognizant

Work highlights

  • Acting for Sandoz in an SPC invalidity action against G.D. Searn and Janssen Sciences Ireland concerning the interpretation of the Supplementary Protection Certificate (SPC) regulation.
  • Supporting AstraZeneca on agreements to manufacture and purchase both the University of Oxford’s Covid-19 vaccine, and AstraZeneca’s monoclonal antibody cocktail for the treatment of Covid-19.
  • Advising Pfizer on various agreements for the supply of the Pfizer/BioNTech investigational BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2.

Carpmaels & Ransford LLP

Carpmaels & Ransford LLPComparative Guides promotional icon applies the vast scientific and technical knowledge of its patent prosecution practice to complex litigation. In the life sciences sector, the ‘thoughtful, pragmatic and astuteIan Kirby secured patent infringement victories on behalf of a number of medical devices and blockbuster drugs companies, while David Wilson took the lead on opposition proceedings before the EPO. Also focusing on life sciences, Jake Marshall leads the advice to clients on IP transactions and commercial agreements. Owing to a high degree of successes in life sciences litigation, Jennifer Antcliff made partner in mid-2020.

Practice head(s):

Hugh Goodfellow; David Wilson; Jake Marshall

Other key lawyers:

Ian Kirby; Jennifer Antcliff; Camilla Balleny; Simon Llewellyn; Sarah Johnson; Simon Keevey-Kothari; Chloe Taylor

Testimonials

With fantastic support from the patent attorney team, who have often clocked up years of experience with the cases in the EPO and beyond, this is one of the best all round European patent litigation teams in London.

David Wilson is enormously experienced on the life sciences side. Ian Kirby is a very canny litigator.

Jennifer Antcliff is a new partner with huge potential.

Ian Kirby is a thoughtful, pragmatic and astute litigator.

We were highly impressed with both the breadth and the depth of the experience of the team.

The Carpmaels team is very thorough in their approach to the matters and consistently provided a high-quality work product. Their strong attention to detail and hard work allowed them to develop a strategy quickly and refine it as the matter progressed.

Carpmaels has a large team in the pharmaceutical/life sciences space that is very knowledgeable about the industry. Carpmaels does a very good job of keeping on top of their matters and communicating with the client to ensure the client is aware of important issues and deadlines.

Camilla Balleny does an excellent job of overseeing a large team responsible for running a large contentious pharmaceutical patent litigation/enforcement program on a pan-EU basis.

Key clients

FibroGen

BMS (formerly Celgene)

BISSELL Homecare, Inc.

Johnson & Johnson, subsidiary AMO Development, LLC

Penguin Random House

Johnson & Johnson, subsidiary Ethicon, Inc.

Harbour BioMed

Amgen Europe GmbH (via Marshall, Gerstein & Borun LLP)

Ceva Santé Animal Health SA

Janssen Pharmaceutica (part of the Johnson & Johnson group)

Janssen Biotech, Inc.

Work highlights

  • Represented Fibrogen in a three-week patent trial involving the defence of seven patents against a revocation claim, a declaration of non-infringement against two, as well as advancing counterclaims for infringement of certain patents involved against Akebia and GSK.
  • Conducted UK and international patent litigation and strategy for BISSELL Homecare.
  • Advised Harbour BioMed on a licence and collaboration agreement for the use of the 47D11 antibody to treat Covid-19.

Dentons

Dentons combines a sophisticated patent prosecution outfit (led by Justin Hill) with a strong bench of litigators, making it well-placed to excel in highly technical disputes. Ongoing highlights include acting for generic pharmaceutical companies in multi-patent infringement and validity proceedings relating to fibre optics technology and SPC invalidity actions. Jennifer Cass and James Marsden were promoted to senior associate in July 2020.

Practice head(s):

Justin Hill

Other key lawyers:

Marie Jansson-Heeks; Jennifer Cass; James Marsden;

Testimonials

A hardworking, experienced and tight-knit team, which know what their clients want and will work unceasingly to achieve it.

Their breadth of experience makes them very easy to work with as they can tackle any of our very varied inventions.

Fantastic team that know their stuff inside and out.

Key clients

ARM Holdings

Dexcom

Emtelle UK Limited

M&S

Positec

Raytheon

Royal Mail Group

Starkey Labs

Tesla

TikTok

Virgin

Zentiva

Work highlights

  • Representing Diagnostics AI in its expedited High Court claims in relation to the government’s selection process of an IT contract for coronavirus testing.
  • Advising Raytheon on its large and complex European patent portfolio comprising hundreds of different patent matters and involving a wide range of cutting-edge technologies.
  • Advising and acting for Emtelle on a high-value UK High Court multi-patent case relating to fibre optic cabling. Emtelle is Defendant in a claim by multinational Prysmian Group for infringement of two patents.

Fieldfisher

The patent litigators at Fieldfisher picked up a number of new mandates in niche areas, including children’s toys and fitness equipment. Practice head David Knight, senior associate Tommy McKenna and associate Christopher Leung are currently defending Peloton against patent infringement claims commenced by a competitor. Life sciences is another key area of activity, particularly in relation to SPC litigation. The team was one of the first to successfully apply for expedited remote appeal hearings in the early stages of Covid-19.

Practice head(s):

David Knight

Other key lawyers:

Tommy McKenna; Christopher Leung

Key clients

Peloton Interactive, Inc

Master Data Centre Inc (a CPA Global company)

MGA Entertainment

Work highlights

  • Acting for high-profile client Peloton in a patent infringement claim commenced by Icon Fitness.
  • Represented Master Data Center in an application before the UKIPO to rectify the register as regards the expiry date of an SPC.
  • Acting for MGA Entertainment, a well-known global designer and distributor of innovative children’s toys, in defending an action brought by Cabo Concepts. The client has been accused of making unjustified threats of patent infringement, which (it is asserted) had the effect of causing a rival business to lose significant volumes of sales and ultimately go out of business.

Reed Smith LLP

Reed Smith LLP maintains a highly integrated IP offering across Europe and the US. Practice head Jonathan Radcliffe ('experienced, incredibly bright, easy to work with, a strategic thinker') frequently advises on large multijurisdictional strategic patent matters, both contentious and non-contentious. Philip Thomas is another key individual.

Practice head(s):

Jonathan Radcliffe

Other key lawyers:

Philip Thomas

Testimonials

The Reed Smith team is a fantastic team, commercially focused with a good eye for strategy. They hone in on the key issues to achieve a good commercial result with the least amount of fuss. They have managed cases during the pandemic with a aplomb, making effective use of technology to ensure that cases keep running smoothly.

Jonathan Radcliffe is experienced, incredibly bright, easy to work with, a strategic thinker.

Jonathan Radcliffe is a stand-out partner who is excellent on legal aspects and very good on technical aspects. He is brilliant with clients and experts alike.

Jonathan Radcliffe is personable and pragmatic, and interested in getting the right outcome. In IP matters he advises with legal insight, but pragmatically.

Reed Smith’s IP team are very commercially aware and understand how IP can be best leveraged to serve their client’s needs. I have been very impressed with their knowledge and nous.

Philip Thomas is highly communicative and commercially minded. He has an excellent understanding of patent law and I rate him very highly. I recommend Philip to my clients without any hesitation.

AA Thornton

Led by Geoff Hussey, AA Thornton’s IP litigation team is often instructed in matters concerning patent entitlement and breaches of confidential information before the High Court and IPEC. Recent highlights related to complex quantum computing technology. The team also advises on licensing and joint collaboration matters, particularly in the hi-tech, manufacturing and biotechnology sectors.

Practice head(s):

Geoff Hussey

Testimonials

For all UK-related IP matters we use the services of AA Thornton. The patent attorneys are very highly-skilled and the advice provided is always well-explained and clear, including the related costs. They are quickly responsive to any communication and are nice people to do business with. This is an outstanding firm.

Key clients

Virgin Enterprises Limited

Admiral Group

Halliburton Energy Services

Jimmy Choo Limited

Cambridge Quantum Computing

Primark

Paul Smith

Radley & Co.

Robert Bosch GmbH

Associated British Foods Plc

Work highlights

  • Acted for Cambridge Quantum Computing in a High Court action relating to breach of contract, breach of confidential information and patent entitlement relating to highly technically complex quantum chemistry.
  • Advised Adolf Nissen Elektrobau on the technical interaction between the patent obviousness issues and the regulatory issues in being able to use road signs in the UK and elsewhere in the world.
  • Successfully assisted medical diagnostics company RSR Limited with upholding a patent in full through the UK courts.

Clifford Chance LLP

In a significant mandate for Clifford Chance LLP’s IP practice, Stephen Reese acted for Pfizer on the global patent licensing and collaboration agreement with BioNTech for the development and commercialisation of a Covid-19 vaccine. Reese co-heads the practice with Vanessa Marsland, who is also highly active on the non-contentious side, having recently advised major computer technology clients on IP-rich technology licence agreements.

Practice head(s):

Stephen Reese; Vanessa Marsland

Testimonials

Their work is very detailed and professional, on another level compared to other firms I have used. Their analysis and conclusions are so well written that even an ignorant person in the field would be able to understand everything.

It is clear that Stephen Reese is a mentor and sets the tone for others.

Key clients

Pfizer Inc

Her Majesty’s Government (HMG), Department for Business, Energy and Industrial Strategy (BEIS)

Telefónica

Cyprus Government

Fontaine Limited

Philip Morris Products, S.A

LZ Labs

Qiddiya Investment Company

The Absolut Company

Gyrus Capital

Volvo Cars

Moorfields Eye Hospital NHS Trust

Work highlights

  • Advising Pfizer on its global patent licensing and collaboration agreement with BioNTech for the development and commercialisation of a Covid-19 vaccine, which was the first Covid-19 vaccine to be approved and deployed in the world.
  • Advising the Vaccine Taskforce on behalf of Her Majesty’s Government on the IP licensing, development, manufacturing and supply of vaccines to the UK population for the treatment of Covid-19, including the regulatory issues facing the Government in connection with the unprecedented circumstances presented by Covid-19.
  • Acted for Philip Morris on its collaboration and distribution licensing arrangements for the “heat not burn” products of KT&G, Korea’s premier tobacco company.

Clyde & Co

Clyde & Co LLP’s IP team is particularly well-known for representing generic pharmaceuticals companies in patent litigation. Elsewhere, the team recently won mandates in the engineering sector and it has experience of handling disputes in the technology sector. Ralph Cox heads up the practice, which was bolstered by the arrival of Chris Williams from Blake Morgan LLP.

Practice head(s):

Ralph Cox

Other key lawyers:

Chris Williams

Testimonials

‘Very good value for money – a firm with international reach and experience, and with very high quality patent advisors, but charges less than the leading firms for equally good work.’

‘Ralph Cox has a very extensive knowledge of patent practice and procedure such that he is fully up-to-date of all and any developments in the area. This means that he is very well placed to advice clients on the latest matters in the law. He is very good with clients, giving clear commercially alert advice. He is also very supportive of clients during what is sometimes a difficult process of IP proceedings.’

Key clients

BiGDUG Limited

Dubar India Limited

Oxford Nanoimaging Limited

The Doctors Laboratory Ltd / TDL Genetics Ltd

Work highlights

  • Representing The Doctors Laboratory and TDL Genetics in a longrunning series of patent infringement and validity proceedings relating to prenatal genetic testing (in particular for Down’s Syndrome).

Keystone Law

At Keystone Law, patent litigator Rebecca Halford–Harrison is active in disputes connected with chemistry-based and technology-rich industries, such as life sciences, energy, and food and beverages. Numerous clients in the cosmetics sector have engaged her team to defend patent infringement claims, requiring strategic guidance across the EU and US. In another notable mandate, the group defended a Bulgarian manufacturer of payment devices in a case over patent type designs.

Other key lawyers:

Rebecca Halford-Harrison; Jeremy Schrire; Simon Chalkley; Fiona Nicolson; Muzaffar Shah; Alexander Carter-Silk; Claire Blewett

Testimonials

Enormously varied skills that can be called on to meet any issue.

I work with Rebecca Halford-Harrison who is a highly gifted adviser. She takes a very commercial view, is able to deal with any IP matter and draws on her superb litigation skills to inform her advice in transactional matters. She is swift, provides clear urgent advice and is a superb resource.

Rebecca Halford-Harrison is utterly brilliant at what she does and goes above and beyond. For that, we are very grateful to have her represent us, looking after a very complicated matter that’s currently ongoing.

Key clients

World Programming Limited

F W Thorpe Plc

Secret Smokehouse Ltd

Veiovia Ltd

Pembrook Products Ltd

Athena Cosmetics, Inc.

HP1 Technologies Ltd

Erda Energy

Avantra (Syslink Xandria Ltd)

Yok Energy Ltd

Adeki Ltd

Datecs OOD

Khemco (UK) Ltd

Work highlights

  • Advised UK beauty product company Pembrook in relation to the defence of a patent infringement claim brought by a US beauty company in the UK initially and then in the US.
  • Advised US-headquartered cosmetics company Athena on numerous intellectual property (patents, designs, copyright, trade marks) and related regulatory matters.
  • Successfully advised the analytics software developer and services provider World Programming, in defending claims of patent and copyright infringement brought against World Programming by one of the world’s largest privately owned software companies, SAS Institute.

Lewis Silkin

Lewis Silkin LLP increased its footprint in the patents space off the back of recent hires to its practice. IP litigation expert Antony Craggs joined from D Young & Co LLP, bringing High Court and IPEC trial experience. In addition, David Swain, who joined from top-flight Hong Kong outfit Deacons, enhanced the commercial and licensing offering. The practice is headed up by Tom Gaunt, who handles opposition proceedings before the EUIPO.

Practice head(s):

Tom Gaunt

Other key lawyers:

David Swain; Antony Craggs

Key clients

Intellectual Ventures

Aptiv Technologies

TDK Lambda

Insights Group

Clear Channel

Orsted

Bacardi

Organics Group plc

Britvic Soft Drinks Limited

Janssen Pharmaceutica NV

Work highlights

  • Instructed by Janssen Pharmaceutica to defend the validity of EP 1951232, a patent which relates to reduction of side effects in the delivery of opioids and EP 2269577, a patent which relates to injectable drug-containing suspensions.
  • Instructed by Biosensors International to defend the validity of three patents, EP 2578186, EP 2417943, EP 2316377, which relate to drug-eluting stents.
  • Assisting Britvic Soft Drinks with establishing a new innovation hub, and the protection of IP generated by this, including competitive intelligence and due diligence searching and analysis.

Venner Shipley LLP

Patent attorney firm Venner Shipley LLP is steadily growing its patent litigation offering through practice head James Tumbridge and highly active partner Paul Harris. Showcasing broad sector strengths, the firm's recent work included handling High Court infringement and entitlement disputes on behalf of fintech, biotechnology and leisure companies. On the non-contentious side, newly-promoted partner Robert Peake advised on patent licensing agreements in the manufacturing sector.

Practice head(s):

James Tumbridge

Other key lawyers:

Paul Harris; Robert Peake

Testimonials

James Tumbridge has impressive knowledge and a pragmatic approach.

Key clients

Amro Biotech

Cambridge Touch Technologies

Claytex

Cubic Pharmaceuticals Ltd.

Ensygnia IP Ltd.

Fiberlean Technologies Ltd.

Fit Out (UK) Ltd.

Howorth Air Technology Ltd.

Ice-world International

Imperial College

Kazia Therapeutics Ltd

MTL Finance Ltd

Neuro-Bio

Work highlights

  • Advising fintech company Ensygnia IP in relation to its patent portfolio, having successfully secured strategic amendments to it, in order for it to bring action against a number of companies using an image-recognition device to enable an individual to use a service.
  • Advised Amro Biotech, and the inventor of a diabetes treatment, against investors in the company that intended to commercialise the invention.
  • Advising Ocean Infinity in relation to potential patent issues (including infringement) for the underwater search part of Ocean Infinity’s business, in the US, Norway and the UK/EU.

Womble Bond Dickinson (UK) LLP

Womble Bond Dickinson (UK) LLP’s Yorkshire-based patent litigation practice is led by practice head James Love, who worked with associate Tim Barber to represent Geofabrics Limited in High Court proceedings over the alleged infringement of one of the client's UK patents in the area of rail technology. Senior counsel Patrick Cantrill advises on commercial IP licensing, joint ventures and corporate transactions.

Practice head(s):

James Love

Other key lawyers:

Tim Barber; Patrick Cantrill

Key clients

Geofabrics Limited

Drax

University of Leeds

TomTom International

Work highlights

  • Representing UK manufacturer Geofabrics in a High Court patent dispute involving the infringement of a UK patent in the field of rail technology.
  • Advising market-leading biomass and coal-fired power station Drax Group on a substantial investment into a company spun out of the University of Leeds, and evaluating the feasibility and scaling up of certain carbon capture technology central to its business.
  • Advising private equity house Puma Investments on IP risks and opportunities arising from investments into a wide range of businesses.

Baker Botts (UK) LLP

Baker Botts (UK) LLP’s IP practice is led by Neil Coulson, who advises on a range of strategic patent matters, primarily in the generic pharmaceuticals, manufacturing and technology sectors. Technology transfers, licensing and risk-minimised product launches constitute the core of the practice.

Practice head(s):

Neil Coulson

Testimonials

The team is not the biggest in the London IP market, but it is highly focused, has great industry knowledge and is led by the eminent Neil Coulson, and the quality of their work is on par with the best in the business. The team has extensive experience in the tech, energy and life sciences sectors.

Responsive, straightforward and flexible (in both the organization of work and the related invoices).’

Neil Coulson is one of the best IP lawyers in the UK market. He has a wealth of experience in complex patent and trademark litigation and transactions, and he is particularly good at coordinating multijurisdictional matters. He is an absolute pleasure to work with, both from a professional and a personal point of view. Highly recommended.’

Heavyweight IP team with deep experience and an excellent level of client care and success rate.’

Neil Coulson – partner – IP – highly accomplished and experienced IP expert who ensures first class service to clients and deeply effective IP strategies.’

The team has great breadth of experience across all IP issues. A particular strength is the practical application of IP law focused on leveraging and achieving the desired commercial result.

The IP team at Baker Botts is outstanding. The legal advice is intelligent, fast and pragamatic, combining legal acumen with an excellent commercial understanding. The team work is excellent and overall a first class service.’

Neil Coulson is a brilliant lawyer and simply wonderful to work with. He does not only have excellent legal skills, his grasp of technical matters is utterly impressive – which is perfect for a patent litigator.

Key clients

Liberty Global

Liberty Media Corporation

Novatek

Rosneft

Zix Corp Systems

Royal National Institute for Blind People

Charles Russell Speechlys LLP

Charles Russell Speechlys LLP offers clients the benefits of its team's expertise in the licensing and collaboration of vaccine patents, and it secured mandates relating to international Covid-19-related R&D and collaboration agreements. Key names at the firm include practice head Mary Bagnall and senior associate Caroline Young, with corporate partners also providing assistance. Recent contentious work pertained to patent infringements in the mining sector.

Practice head(s):

Mary Bagnall

Other key lawyers:

Caroline Young

Key clients

Sandvik Group

Deepak Nitrite

National Pharmacy Association Limited

DriWay

Atkins

YouView

Norsk Titanium

Emergex Vaccines

Immodulon Therapeutics

Essity

Pritchard Spray Technology

Work highlights

  • Advised Emergex Vaccines on its global collaboration with the Brazilian government for Covid-19 vaccines, Covid-19 clinical trials in Switzerland, and Emergex Vaccines’s $11m equity fundraising.
  • Advised the shareholders of Veriton on its sale to SERB Specialty Pharmaceuticals, a European specialty pharma business backed by Charterhouse Capital Partners.
  • Advising Sandvik Group on patent disputes and potential patent disputes in the UK, involving a range of technology, including metal cutting tools, rock crushing and mining machinery and equipment.

Norton Rose Fulbright

Norton Rose Fulbright hired Paul Joseph from RPC in 2020, which is intended to enhance its patent litigation offering. In more recent developments, the London team was bolstered by the recent arrival of Jane Caskey from the Toronto office, as well as Zayed Al Jamil's promotion to partner. Areas of activity for the practice include transport, life sciences and energy. Practice head Mike Knapper advises on licensing deals, collaborations, technology transfers and other transactional matters.

Practice head(s):

Mike Knapper

Other key lawyers:

Paul Joseph; Jane Caskey; Zayed Al Jamil

Key clients

Japan Tobacco International

Shell

Northern Trust

Schweppes International

Work highlights

  • Advising Japan Tobacco Internationa on a number of patent licensing matters opposite licensees and suppliers of technologies in Europe and Asia.
  • Advising Shell on a patent infringement claim in relation to Pay at Pump technology.
  • Advising Schweppes International Limited in relation to patents (filing strategy and licensing, freedom to operate opinions, third party watch and potential oppositions) across the Suntory Food and Beverage Europe business unit.

Stevens & Bolton LLP

Stevens & Bolton LLP has a strong offering in the patents space, with its workload covering advice on matters such as patent and know-how licensing, clearance issues and litigation. The practice is led by Tom Lingard and benefits from the additional expertise of Charlotte Tillett and Tom Collins. Clients span the technology and life sciences sectors, with both larger corporates and smaller businesses turning to the firm for advice.

Practice head(s):

Tom Lingard

Other key lawyers:

Charlotte Tillett; Tom Collins

Testimonials

Friendly and responsive. Willingness to help. Sticking to timelines. Billing transparency – good information given in advance and then keeping to the costs given – this is important when the bills are relatively high.

Charlotte Tillett is very responsive and friendly with a can-do attitude – if she can’t help, she will direct me to a colleague that can.

Tom Collins is very thorough. Good input which my client found very helpful on a collaboration/MTA agreement where IP was an issue.

Key clients

Pycom Limited

Work highlights

  • Supporting a global biotechnology company in relation to its highly valuable patent and know-how licensing.
  • Advising fast-growing UK tech company Pycom on a High Court breach of confidence claim and related patent entitlement issues.
  • Representing a leading worldwide biotech company on a payment and trade secrets dispute concerning a patent and know-how licence agreement.